VivoSim Labs, Inc. Other Nonoperating Income (Expense)
VivoSim Labs, Inc. (VIVS) reported Other Nonoperating Income (Expense) of $0 for the 12-month period ending 2023-03-31, per its 10-K filed 2023-07-14.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2023-07-14
- VivoSim Labs, Inc. other nonoperating income (expense) for the quarter ending 2023-03-31 was $0.00.
- VivoSim Labs, Inc. other nonoperating income (expense) for the quarter ending 2022-12-31 was $0.00.
- VivoSim Labs, Inc. other nonoperating income (expense) for the quarter ending 2022-09-30 was $0.00.
- VivoSim Labs, Inc. other nonoperating income (expense) for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. other nonoperating income (expense) for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- VivoSim Labs, Inc. other nonoperating income (expense) for fiscal 2022 was $25.00K, a 316.67% increase from fiscal 2021.
- VivoSim Labs, Inc. other nonoperating income (expense) for fiscal 2021 was $6.00K, a 99.61% decline from fiscal 2020.
- VivoSim Labs, Inc. other nonoperating income (expense) for fiscal 2020 was $1.53M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 77 month | Other Nonoperating Income (Expense) 80 month | Other Nonoperating Income (Expense) 83 month |
|---|---|---|---|---|---|---|---|
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $0.00 derived: sum of 2 quarters · filed 2023-07-14 | $0.00 derived: sum of 3 quarters · filed 2023-07-14 | $0.00 10-K · filed 2023-07-14 | |||
| 2022-12-31 | $0.00 10-Q · filed 2023-02-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | $0.00 10-Q · filed 2023-02-09 | $0.00 derived: sum of 4 quarters · filed 2023-07-14 | |||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 3 quarters · filed 2023-07-14 | $0.00 derived: sum of 4 quarters · filed 2023-07-14 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 2 quarters · filed 2023-07-14 | $0.00 derived: sum of 3 quarters · filed 2023-07-14 | $0.00 derived: sum of 4 quarters · filed 2023-07-14 | |||
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $0.00 derived: sum of 2 quarters · filed 2023-07-14 | $0.00 derived: sum of 3 quarters · filed 2023-07-14 | $25.00K 10-K · filed 2023-07-14 | |||
| 2021-12-31 | $0.00 10-Q · filed 2023-02-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | $25.00K 10-Q · filed 2023-02-09 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $25.00K 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | $25.00K 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | $6.00K 10-K · filed 2022-06-10 | ||||||
| 2020-03-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $1.27M derived: sum of 2 quarters · filed 2021-06-15 | $1.53M derived: sum of 3 quarters · filed 2021-06-15 | $1.53M 10-K · filed 2021-06-15 | |||
| 2019-12-31 | $1.19M 10-Q · filed 2020-02-10 | $1.45M derived: sum of 2 quarters · filed 2020-02-10 | $1.45M 10-Q · filed 2020-02-10 | ||||
| 2019-09-30 | $267.00K 10-Q · filed 2019-11-07 | $267.00K 10-Q · filed 2019-11-07 | |||||
| 2019-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | $0.00 derived: sum of 2 quarters · filed 2020-05-28 | $0.00 derived: sum of 3 quarters · filed 2020-05-28 | $0.00 10-K · filed 2020-05-28 | |||
| 2018-12-31 | $0.00 10-Q · filed 2020-02-10 | $0.00 derived: sum of 2 quarters · filed 2020-02-10 | $0.00 10-Q · filed 2020-02-10 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |||||
| 2018-03-31 | -$12.00K 10-K · filed 2019-06-03 | ||||||
| 2017-03-31 | $0.00 10-K · filed 2018-05-31 | ||||||
| 2016-03-31 | $0.00 10-K · filed 2018-05-31 | ||||||
| 2015-03-31 | $0.00 10-K · filed 2015-06-09 | ||||||
| 2014-03-31 | $0.00 10-K · filed 2015-06-09 | -$30.00K 10-K · filed 2014-06-10 | |||||
| 2013-12-31 | -$30.00K 10-Q · filed 2014-02-06 | ||||||
| 2013-09-30 | -$30.00K 10-Q · filed 2013-11-08 | ||||||
| 2013-03-31 | $0.00 10-K · filed 2015-06-09 | ||||||
| 2012-12-31 | -$9.00K 10-K · filed 2015-06-09 | ||||||
| 2012-09-30 | $1.00K 10-Q · filed 2013-11-08 | $1.00K 10-Q · filed 2013-11-08 | |||||
| 2012-03-31 | -$9.00K 10-K · filed 2015-06-09 | ||||||
| 2011-12-31 | -$4.00K 10-K · filed 2014-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |